Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
5,5 USD | 0,00% |
|
-1,79% | +5,16% |
Attività
Numero di dipendenti: 134
Vendite per attività
USD in Milioni | 2021 | Peso | 2022 | Peso | Delta |
---|---|---|---|---|---|
Injectable Drugs
100,0
%
| 172 | 100,0 % | 317 | 100,0 % | +84,56% |
Vendite per regione
USD in Milioni | 2021 | Peso | 2022 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 172 | 100,0 % | 317 | 100,0 % | +84,56% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Michael Graves
CEO | Chief Executive Officer | 61 | 01/11/13 |
Steven B. Ratoff
DFI | Director of Finance/CFO | 81 | 01/03/07 |
Ryan Debski
CMP | Compliance Officer | - | 01/05/21 |
Reed McClung
PRN | Corporate Officer/Principal | - | - |
John Kimmet
SAM | Sales & Marketing | - | 01/01/20 |
Debra M. Hussain
PRN | Corporate Officer/Principal | - | 18/07/22 |
Daniel O'Connor
PRN | Corporate Officer/Principal | - | 01/01/07 |
Charles Wescott
PRN | Corporate Officer/Principal | - | - |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Steven B. Ratoff
DFI | Director of Finance/CFO | 81 | 01/03/07 |
Jennifer Simpson
BRD | Director/Board Member | 55 | 28/08/19 |
Richard Edlin
BRD | Director/Board Member | 63 | 17/03/17 |
Michael Graves
CEO | Chief Executive Officer | 61 | 01/11/13 |
Robert Glenning
BRD | Director/Board Member | 63 | 01/07/16 |
Luciana Borio
BRD | Director/Board Member | 53 | 28/04/21 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 17 539 701 | 11 425 564 ( 65,14 %) | 4 552 730 ( 25,96 %) | 65,14 % |
Coordinate società
Eagle Pharmaceuticals, Inc.
50 Tice Boulevard Suite 315
07677-9991, Woodcliff Lake
+201 326 5300
http://www.eagleus.com![Indirizzo Eagle Pharmaceuticals, Inc.(EGRX)](https://cdn.zonebourse.com/static/address/15758349.png)
Settore
Variaz. 1 gen. | Capi. | |
---|---|---|
+5,16% | 71,43 Mln | |
+22,78% | 9,56 Mrd | |
-21,31% | 4,48 Mrd | |
+30,09% | 4,85 Mrd | |
+24,78% | 3,9 Mrd | |
-2,11% | 1,99 Mrd | |
+11,03% | 2,01 Mrd | |
-36,28% | 1,89 Mrd | |
-43,19% | 1,77 Mrd | |
-0,50% | 1,64 Mrd |
- Borsa valori
- Azioni
- Azione EGRX
- Società Eagle Pharmaceuticals, Inc.